Cooper Companies
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 33 in the most recent period (2026/Q3).
- Total institutional ownership rose 2.1 percentage points.
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 111.26% +2.08pp
- Institutions
- 794 -33
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-09-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 43 buys · 6 sells
| Name | Role | Stake |
|---|---|---|
| Robert Weiss | Independent Director | 0.29% |
| Albert White | Strategic Advisor | 0.13% |
| Daniel McBride | Executive VP, COO General Counsel & Secretary | 0.09% |
| Holly Sheffield | President of CooperSurgical, Inc. | 0.02% |
| Colleen Jay | Independent Director | 0.02% |
| Lawrence Kurzius | Independent Director | 0.02% |
| Brian Andrews | Chief Financial Officer | 0.02% |
| Gerard Warner | President of CooperVision, Inc. | 0.01% |
| Walter Rosebrough | Interim Executive Chair | 0.01% |
| Teresa Madden | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-15 | Lawrence Kurzius | Independent Director | Open Market Acquisition | +10,000 | $54.93 |
| 2026-09-13 | Lawrence Kurzius | Independent Director | Open Market Acquisition | +10,000 | $53.92 |
| 2026-09-13 | Walter Rosebrough | Interim Executive Chair | Open Market Acquisition | +10,000 | $54.11–54.29 |
| 2026-09-10 | Paul Keel | Independent Director | Open Market Acquisition | +4,701 | $53.18 |
| 2026-06-30 | Paul Keel | Independent Director | Other Derivative Acquisition | +2,814 | -- |
| 2026-03-31 | Robert Weiss | Independent Director | Other Derivative Acquisition | +3,779 | -- |
| 2026-03-31 | Robert Weiss | Independent Director | Derivative Exercise and Retained | +3,654 | -- |
| 2026-03-31 | Teresa Madden | Independent Director | Other Derivative Acquisition | +3,779 | -- |
| 2026-03-31 | Teresa Madden | Independent Director | Derivative Exercise and Retained | +3,322 | -- |
| 2026-03-31 | Lawrence Kurzius | Independent Director | Other Derivative Acquisition | +3,779 | -- |
| 2026-03-31 | Lawrence Kurzius | Independent Director | Derivative Exercise and Retained | +3,322 | -- |
| 2026-03-31 | Cynthia Lucchese | Independent Director | Other Derivative Acquisition | +3,779 | -- |
| 2026-03-31 | Cynthia Lucchese | Independent Director | Derivative Exercise and Retained | +3,322 | -- |
| 2026-03-31 | Walter Rosebrough | Interim Executive Chair | Other Derivative Acquisition | +3,779 | -- |
| 2026-03-31 | Walter Rosebrough | Interim Executive Chair | Derivative Exercise and Retained | +832 | -- |
| 2026-03-31 | Colleen Jay | Independent Director | Other Derivative Acquisition | +4,157 | -- |
| 2026-03-31 | Colleen Jay | Independent Director | Derivative Exercise and Retained | +3,322 | -- |
| 2026-03-31 | Maria Rivas | Independent Director | Other Derivative Acquisition | +3,779 | -- |
| 2026-03-31 | Maria Rivas | Independent Director | Derivative Exercise and Retained | +3,322 | -- |
| 2026-03-31 | Barbara Carbone | Independent Director | Other Derivative Acquisition | +3,779 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:59:36 · For reference only, not investment advice and not tailored to your situation.
Cooper Companies discussion 0 comments